CD8A and neoplasm: In a mouse model, injecting CD8+ T cells with CRNDE-knockdown decreases tumor size, increases the number of IFN-γ and TNF-α-producing CD8+ T cells, decreases TIM-3 expression, and increases miR expression -545-5p, activating the antitumor immune response of CD8+ T lymphocytes [63].